Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02958176 · ClinicalTrials.gov registry record · NA
Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder
A NA study of Female Sexual Arousal Disorder, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT02958176: Completed NA study of Female Sexual Arousal Disorder, sponsored by University of Texas at Austin.
NCT02958176 is a NA study of Female Sexual Arousal Disorder that has completed, run by University of Texas at Austin. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02958176, a NA study of Female Sexual Arousal Disorder, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
Low resting heart rate variability (HRV) has been associated with sexual arousal problems and overall sexual dysfunction in women. Research has indicated that HRV biofeedback leads to increases in HRV as well as improvements in symptoms associated with several psychological disorders, some of which are comorbid with sexual arousal problems in women. Autogenic training also facilitates increases in HRV and was recently associated with acute increases in sexual arousal among sexually healthy women. The primary aim of the current study is to examine the efficacy of HRV biofeedback, with and without autogenic training, for the treatment of female sexual arousal disorder (FSAD).
Conditions Studied
Interventions
- BEHAVIORAL HRV Biofeedback
- BEHAVIORAL Autogenic Training
Study Locations (1)
Texas
- The University of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-01 |
| Phase | NA |
What the finished NCT02958176 record still lists
NCT02958176 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Female Sexual Arousal Disorder appearing as the primary indexed condition, and to 2 interventions - of which HRV Biofeedback is the first listed.
NCT02958176 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02958176 about?
NCT02958176 is a clinical study titled "Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder". Low resting heart rate variability (HRV) has been associated with sexual arousal problems and overall sexual dysfunction in women. Research has indicated that HRV biofeedback leads to increases in HRV as well as improvements in symptoms associated with several psychological disorders, some of which ...
What is the current status of trial NCT02958176?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2016-10. Estimated completion is 2018-01.
What conditions does trial NCT02958176 study?
This clinical trial studies the following conditions: Female Sexual Arousal Disorder.
What interventions are being tested in trial NCT02958176?
The interventions under investigation include: HRV Biofeedback (BEHAVIORAL), Autogenic Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02958176?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02958176 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Female Sexual Arousal Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02958176's enrollment target sits among peer trials
65 1144th of 2000 higher than 854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia